OS Therapies OSTX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $22.4M+492% | $16.36M+476% | $8.43M+182% | $5.89M+164% | $3.79M+33.9% | ||
| $11.47M+55.1% | $12.34M+211% | $11.25M+458% | $9.35M+877% | $7.4M+574% | ||
| -$33.87M-203% | -$28.71M-321% | -$19.68M-293% | -$15.24M-378% | -$11.18M-185% | ||
| —— | —— | —— | —— | —— | ||
| -$1.4M-1,089% | -$48.14K+97.7% | $1.4M+160% | $962.08K+129% | -$117.7K+96.6% | ||
| —— | —— | —— | —— | —— | ||
| -$35.27M-212% | -$28.75M-224% | -$18.28M-149% | -$14.28M-121% | -$11.3M-52.6% | ||
| -$1.08+14.3% | -$0.99+25.6% | -$1.22+20.8% | -$1.19+31.6% | -$1.26+35.4% | ||
| -$33.39M-199% | -$28.34M-316% | -$19.44M-289% | -$15.13M-375% | -$11.18M-185% | ||
| -$33.87M-203% | -$28.71M-321% | -$19.68M-293% | -$15.24M-378% | -$11.18M-185% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is OS Therapies profitable?
- OS Therapies is not currently profitable: it reported a net loss of $35.3M over the trailing twelve months.
- What is OS Therapies's earnings per share?
- OS Therapies's diluted EPS over the trailing twelve months is $-1.08.
- Where does OS Therapies's income statement data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.